Indivisible Partners’s Protara Therapeutics TARA Stock Holding History

Indivisible Partners’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$156K	Buy	+51,124	New	+$199K	0.01%	730

Other funds holding TARA

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Indivisible Partners's TARA Position: Q3 2026 in Review

Indivisible Partners opened a new position in Protara Therapeutics (TARA) in Q3 2026: 51,124 shares worth $156K. The stake represents 0.01% of the portfolio and ranks #730 among its holdings.

9 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

Indivisible Partners held 51,124 shares of Protara Therapeutics worth $156K as of Q3 2026.
Protara Therapeutics was a new Indivisible Partners position in Q3 2026.
Protara Therapeutics made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #730 holding.
9 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.